Post

Sino Biological Inc. (Beijing, China). 2024 revenue ~¥1B. Recombinant proteins, antibodies, kits. 15K+ recombinant proteins. HEK293/CHO expression. CRO services: custom antibody, protein production. CRDMO platform.

12:56:57 AM · Jul 9, 2026
Sign in to reply and join the conversation.